Actinium Pharmaceuticals, Inc. (ATNM)
0.95
-0.06
(-5.94%)
USD |
NYAM |
Jun 25, 16:00
0.96
+0.01
(+1.05%)
After-Hours: 20:00
Actinium Pharmaceuticals Cash and Short Term Investments (Quarterly) : 42.13M for March 31, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 42.13M |
| December 31, 2025 | 48.00M |
| September 30, 2025 | 53.39M |
| June 30, 2025 | 59.93M |
| March 31, 2025 | 65.32M |
| December 31, 2024 | 72.90M |
| September 30, 2024 | 78.66M |
| June 30, 2024 | 86.04M |
| March 31, 2024 | 84.06M |
| December 31, 2023 | 76.68M |
| September 30, 2023 | 82.98M |
| June 30, 2023 | 91.28M |
| March 31, 2023 | 94.92M |
| December 31, 2022 | 109.31M |
| September 30, 2022 | 112.21M |
| June 30, 2022 | 116.72M |
| March 31, 2022 | 72.41M |
| December 31, 2021 | 78.22M |
| September 30, 2021 | 82.08M |
| June 30, 2021 | 81.96M |
| March 31, 2021 | 72.30M |
| December 31, 2020 | 63.61M |
| September 30, 2020 | 48.28M |
| June 30, 2020 | 53.51M |
| March 31, 2020 | 5.99M |
| Date | Value |
|---|---|
| December 31, 2019 | 9.302M |
| September 30, 2019 | 14.36M |
| June 30, 2019 | 19.61M |
| March 31, 2019 | 9.965M |
| December 31, 2018 | 13.71M |
| September 30, 2018 | 14.85M |
| June 30, 2018 | 21.51M |
| March 31, 2018 | 26.80M |
| December 31, 2017 | 17.40M |
| September 30, 2017 | 20.54M |
| June 30, 2017 | 11.46M |
| March 31, 2017 | 17.09M |
| December 31, 2016 | 20.55M |
| September 30, 2016 | 15.56M |
| June 30, 2016 | 20.49M |
| March 31, 2016 | 22.24M |
| December 31, 2015 | 25.68M |
| September 30, 2015 | 24.77M |
| June 30, 2015 | 25.97M |
| March 31, 2015 | 19.30M |
| December 31, 2014 | 6.707M |
| September 30, 2014 | 11.75M |
| June 30, 2014 | 14.67M |
| March 31, 2014 | 5.878M |
| December 31, 2013 | 5.533M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 851.46M |
| Alnylam Pharmaceuticals, Inc. | 3.009B |
| Anika Therapeutics, Inc. | 41.02M |
| Savara, Inc. | 202.77M |
| Vericel Corp. | 145.34M |